XERIS PHARMACEUTICALS INC Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five
XERIS PHARMACEUTICALS INC had Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five of $2.00 million as of 2018-12-31, per its 10-K filed 2019-03-06.
Discontinued › Notes › Debt
us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive · last filed 2019-03-06
- 2018-12-31: Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five $2.00M.
- 2018-09-30: Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five $2.00M.
- 2018-06-30: Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five $1.28M.
| Period end | Long-term Debt, Maturities, Repayments of Principal in Rolling after Year Five |
|---|---|
| 2018-12-31 | $2.00M 10-K · filed 2019-03-06 |
| 2018-09-30 | $2.00M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.28M 10-Q · filed 2018-08-14 |